Sign up to save your podcasts
Or
Share A Look at ACC's Scientific Statement on Inflammation and CVD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Look at ACC's Scientific Statement on Inflammation and CVD
In this week's View, Dr. Eagle looks at an ACC Scientific Statement highlighting inflammation and its role in cardiovascular disease (CVD). He then explores left atrial appendage occlusion (LAAO) in patients with prior intracranial hemorrhage or ischemic stroke. Finally, Dr. Eagle discusses the recently released NEWTON-CABG CardioLink-5 trial on the use of evolocumab in the reduction of saphenous vein graft (SVG) disease rates.
Subscribe to Eagle's Eye View
View all episodes
By American College of Cardiology
4.7
129129 ratings
In this week's View, Dr. Eagle looks at an ACC Scientific Statement highlighting inflammation and its role in cardiovascular disease (CVD). He then explores left atrial appendage occlusion (LAAO) in patients with prior intracranial hemorrhage or ischemic stroke. Finally, Dr. Eagle discusses the recently released NEWTON-CABG CardioLink-5 trial on the use of evolocumab in the reduction of saphenous vein graft (SVG) disease rates.
Subscribe to Eagle's Eye View
More shows like Eagle's Eye View: Your Weekly CV Update From ACC.org
View all
JAMA Editors' Summary
133 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
502 Listeners
JACC This Week
167 Listeners
This Week in Cardiology
901 Listeners
Mayo Clinic Talks
297 Listeners
Core IM | Internal Medicine Podcast
1,141 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
65 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
90 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
365 Listeners
Cardionerds: A Cardiology Podcast
441 Listeners
The Curious Clinicians
374 Listeners
Mayo Clinic Cardiovascular CME
31 Listeners